Cargando…

Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana

Sickle cell disease (SCD) is the most common clinically significant hemoglobinopathy, characterized by painful episodes, anemia, high risk of infection, and other acute and chronic complications. In Africa, where the disease is most prevalent, large longitudinal data on patients and their outcomes a...

Descripción completa

Detalles Bibliográficos
Autores principales: Paintsil, Vivian, Amuzu, Evans Xorse, Nyanor, Isaac, Asafo-Adjei, Emmanuel, Mohammed, Abdul Razak, Yawnumah, Suraj Abubakar, Oppong-Mensah, Yaa Gyamfua, Nguah, Samuel Blay, Obeng, Paul, Dogbe, Elliot Eli, Jonas, Mario, Nembaware, Victoria, Mazandu, Gaston, Ohene-Frempong, Kwaku, Wonkam, Ambroise, Makani, Julie, Ansong, Daniel, Osei-Akoto, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908904/
https://www.ncbi.nlm.nih.gov/pubmed/35281803
http://dx.doi.org/10.3389/fgene.2022.802355
_version_ 1784665973241937920
author Paintsil, Vivian
Amuzu, Evans Xorse
Nyanor, Isaac
Asafo-Adjei, Emmanuel
Mohammed, Abdul Razak
Yawnumah, Suraj Abubakar
Oppong-Mensah, Yaa Gyamfua
Nguah, Samuel Blay
Obeng, Paul
Dogbe, Elliot Eli
Jonas, Mario
Nembaware, Victoria
Mazandu, Gaston
Ohene-Frempong, Kwaku
Wonkam, Ambroise
Makani, Julie
Ansong, Daniel
Osei-Akoto, Alex
author_facet Paintsil, Vivian
Amuzu, Evans Xorse
Nyanor, Isaac
Asafo-Adjei, Emmanuel
Mohammed, Abdul Razak
Yawnumah, Suraj Abubakar
Oppong-Mensah, Yaa Gyamfua
Nguah, Samuel Blay
Obeng, Paul
Dogbe, Elliot Eli
Jonas, Mario
Nembaware, Victoria
Mazandu, Gaston
Ohene-Frempong, Kwaku
Wonkam, Ambroise
Makani, Julie
Ansong, Daniel
Osei-Akoto, Alex
author_sort Paintsil, Vivian
collection PubMed
description Sickle cell disease (SCD) is the most common clinically significant hemoglobinopathy, characterized by painful episodes, anemia, high risk of infection, and other acute and chronic complications. In Africa, where the disease is most prevalent, large longitudinal data on patients and their outcomes are lacking. This article describes the experiences of the Kumasi Center for SCD at the Komfo Anokye Teaching Hospital (KCSCD-KATH), a Sickle Pan-African Research Consortium (SPARCO) site and a SickleInAfrica Consortium member, in establishing a SCD registry for the evaluation of the outcomes of patients. It also provides a report of a preliminary analysis of the data. The process of developing the registry database involved comprehensive review of the center’s SCD patient medical records, incorporating data elements developed by the SickleInAfrica Consortium and obtaining ethical clearance from the local Institutional Review Board. From December 2017 to March 2020, 3,148 SCD patients were enrolled into the SCD registry. Enrollment was during the SCD outpatient clinic visits or through home visits. A significant proportion of the patients was from the newborn screening cohort (50.3%) and was males (52.9%). SCD-SS, SCD-SC, and Sβ (+)thalassemia were seen in 67.2, 32.5, and 0.3% patients, respectively. The majority of the patients were in a steady state at enrollment; however, some were enrolled after discharge for an acute illness admission. The top two clinical diagnoses for SCD-SS patients were sickle cell painful events and acute anemia secondary to hyperhemolysis with incidence rates of 141.86 per 10,000 person months of observation (PMO) and 32.74 per 10,000 PMO, respectively. In SCD-SC patients, the top two diagnoses were sickle cell painful events and avascular necrosis with incidence rates of 203.09 per 10,000 PMO and 21.19 per 10,000 PMO, respectively. The SPARCO Kumasi site has developed skills and infrastructure to design, manage, and analyze data in the SCD registry. The newborn screening program and alternative recruitment methods such as radio announcement and home visits for defaulting patients were the key steps taken in enrolling patients into the registry. The registry will provide longitudinal data that will help improve knowledge of SCD in Ghana and Africa through research.
format Online
Article
Text
id pubmed-8908904
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89089042022-03-11 Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana Paintsil, Vivian Amuzu, Evans Xorse Nyanor, Isaac Asafo-Adjei, Emmanuel Mohammed, Abdul Razak Yawnumah, Suraj Abubakar Oppong-Mensah, Yaa Gyamfua Nguah, Samuel Blay Obeng, Paul Dogbe, Elliot Eli Jonas, Mario Nembaware, Victoria Mazandu, Gaston Ohene-Frempong, Kwaku Wonkam, Ambroise Makani, Julie Ansong, Daniel Osei-Akoto, Alex Front Genet Genetics Sickle cell disease (SCD) is the most common clinically significant hemoglobinopathy, characterized by painful episodes, anemia, high risk of infection, and other acute and chronic complications. In Africa, where the disease is most prevalent, large longitudinal data on patients and their outcomes are lacking. This article describes the experiences of the Kumasi Center for SCD at the Komfo Anokye Teaching Hospital (KCSCD-KATH), a Sickle Pan-African Research Consortium (SPARCO) site and a SickleInAfrica Consortium member, in establishing a SCD registry for the evaluation of the outcomes of patients. It also provides a report of a preliminary analysis of the data. The process of developing the registry database involved comprehensive review of the center’s SCD patient medical records, incorporating data elements developed by the SickleInAfrica Consortium and obtaining ethical clearance from the local Institutional Review Board. From December 2017 to March 2020, 3,148 SCD patients were enrolled into the SCD registry. Enrollment was during the SCD outpatient clinic visits or through home visits. A significant proportion of the patients was from the newborn screening cohort (50.3%) and was males (52.9%). SCD-SS, SCD-SC, and Sβ (+)thalassemia were seen in 67.2, 32.5, and 0.3% patients, respectively. The majority of the patients were in a steady state at enrollment; however, some were enrolled after discharge for an acute illness admission. The top two clinical diagnoses for SCD-SS patients were sickle cell painful events and acute anemia secondary to hyperhemolysis with incidence rates of 141.86 per 10,000 person months of observation (PMO) and 32.74 per 10,000 PMO, respectively. In SCD-SC patients, the top two diagnoses were sickle cell painful events and avascular necrosis with incidence rates of 203.09 per 10,000 PMO and 21.19 per 10,000 PMO, respectively. The SPARCO Kumasi site has developed skills and infrastructure to design, manage, and analyze data in the SCD registry. The newborn screening program and alternative recruitment methods such as radio announcement and home visits for defaulting patients were the key steps taken in enrolling patients into the registry. The registry will provide longitudinal data that will help improve knowledge of SCD in Ghana and Africa through research. Frontiers Media S.A. 2022-02-24 /pmc/articles/PMC8908904/ /pubmed/35281803 http://dx.doi.org/10.3389/fgene.2022.802355 Text en Copyright © 2022 Paintsil, Amuzu, Nyanor, Asafo-Adjei, Mohammed, Yawnumah, Oppong-Mensah, Nguah, Obeng, Dogbe, Jonas, Nembaware, Mazandu, Ohene-Frempong, Wonkam, Makani, Ansong and Osei-Akoto. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Paintsil, Vivian
Amuzu, Evans Xorse
Nyanor, Isaac
Asafo-Adjei, Emmanuel
Mohammed, Abdul Razak
Yawnumah, Suraj Abubakar
Oppong-Mensah, Yaa Gyamfua
Nguah, Samuel Blay
Obeng, Paul
Dogbe, Elliot Eli
Jonas, Mario
Nembaware, Victoria
Mazandu, Gaston
Ohene-Frempong, Kwaku
Wonkam, Ambroise
Makani, Julie
Ansong, Daniel
Osei-Akoto, Alex
Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana
title Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana
title_full Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana
title_fullStr Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana
title_full_unstemmed Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana
title_short Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana
title_sort establishing a sickle cell disease registry in africa: experience from the sickle pan-african research consortium, kumasi-ghana
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908904/
https://www.ncbi.nlm.nih.gov/pubmed/35281803
http://dx.doi.org/10.3389/fgene.2022.802355
work_keys_str_mv AT paintsilvivian establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT amuzuevansxorse establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT nyanorisaac establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT asafoadjeiemmanuel establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT mohammedabdulrazak establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT yawnumahsurajabubakar establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT oppongmensahyaagyamfua establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT nguahsamuelblay establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT obengpaul establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT dogbeellioteli establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT jonasmario establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT nembawarevictoria establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT mazandugaston establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT ohenefrempongkwaku establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT wonkamambroise establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT makanijulie establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT ansongdaniel establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT oseiakotoalex establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana
AT establishingasicklecelldiseaseregistryinafricaexperiencefromthesicklepanafricanresearchconsortiumkumasighana